author-photo

Kristen M. Pappas

4

Papers

7

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

The DART Study: Part 1 results from the dalantercept plus axitinib dose escalation and expansion cohorts in patients with advanced renal cell carcinoma (RCC).

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
DART Study: A phase II randomized trial of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma (RCC): Results from Part 1.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
The DART Study: A phase 2 randomized double-blind study of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma (RCC).

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A two-part phase 2 randomized study of dalantercept and axitinib versus placebo plus axitinib in advanced renal cell carcinoma: Results from the part 1 dose escalation cohorts.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)